We exist to increase awareness of treatment options available to patients with PE, to reduce the worldwide incidence of PE, and to further scientific discovery
We look forward to bringing the PRISM Program to more cities across the country. Upcoming meetings are planned in New York, Chicago, San Diego, and Las Vegas.
To learn more about our newest initiative, the PRISM Program visit: https://t.co/xWgOVFa8TX
@penumbrainc
Join the PERT Consortium CME Dinner Series in New York City for an evening of peer discussion focused on the latest clinical evidence, innovation, and data-driven approaches to pulmonary embolism (PE) care.
Register here: https://t.co/X9K05ruKqo
The program will feature expert faculty from Mount Sinai Health System, Columbia University Irving Medical Center, and Albert Einstein College of Medicine discussing:
• PE risk stratification and patient pathways
• STORM trial and PE guideline updates
• Real-world clinical evidence
• Interactive PE case presentations
The Westin New York Grand Central
Thursday, June 4, 2026
5:45–8:00 PM
This educational activity has been approved for AMA PRA Category 1 Credits™ and ASRT Category A continuing education credit.
#PERTConsortium #PulmonaryEmbolism #PECare #InterventionalRadiology #InterventionalCardiology #CME #MedicalEducation
Join the PERT Consortium CME Dinner Series in New York City for an evening of peer discussion focused on the latest clinical evidence, innovation, and data-driven approaches to pulmonary embolism (PE) care.
The program will feature expert faculty from Mount Sinai Health System and Albert Einstein College of Medicine discussing:
• PE risk stratification and patient pathways
• STORM trial and PE guideline updates
• Real-world clinical evidence
• Interactive PE case presentations
📷 The Westin New York Grand Central
📷 Thursday, June 4, 2026
📷 5:45–8:00 PM
This educational activity has been approved for AMA PRA Category 1 Credits™ and ASRT Category A continuing education credit.
#PERTConsortium #PulmonaryEmbolism #PECare #InterventionalRadiology #InterventionalCardiology #CME #MedicalEducation
We’re proud to be a sponsor of the HI-PEITHO trial, which was recently published in the New England Journal of Medicine. Conducted in collaboration with Boston Scientific and the University Medical Center Mainz, this trial is a defining moment for pulmonary embolism care and was designed to close critical evidence gaps for intermediate-risk patients who are managed with anticoagulation (AC) alone.
HI-PEITHO is a randomized controlled trial evaluating the use of EKOS plus AC compared with AC alone for the treatment of patients with intermediate-risk pulmonary embolism. Patients treated with EKOS had superior clinical outcomes with no increase in major bleeding and zero intracranial hemorrhagic events
Learn more here: https://t.co/JRoswqApfs